Medifast, Inc.
| Security | MED / Medifast, Inc. |
| Insider | Jonathan Barrett MacKenzie |
This page shows the track record and history of MacKenzie Jonathan Barrett
insider trades in Medifast, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company.
It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean
it is illegal for them to make any
trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis
In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Jonathan Barrett MacKenzie in MED / Medifast, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
| Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Max |
Price at Max |
Max Profit ($) |
Max Return (%) |
|---|---|---|---|---|---|---|---|
| There are no known unplanned open-market trades for this insider |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Sales - Short Term Loss Analysis
In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Jonathan Barrett MacKenzie in MED / Medifast, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
| Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Min |
Price at Min |
Max Loss Avoided ($) |
Max Loss Avoided (%) |
|---|---|---|---|---|---|---|---|
| There are no known unplanned open-market trades for this insider |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Transaction History
| File Date |
Trade Date |
Form | Insider | Ticker | Security Title | Code | Direct | Exercise Price |
Unit Price |
Units Changed |
Value Changed (1K) |
Remaining Options |
Remaining Shares |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-27 | 2026-03-25 | 4 | MacKenzie Jonathan Barrett | MED | Common Stock | D | 10,830 | 20,838 | ||||||
| 2026-03-27 | 2026-03-25 | 4 | MacKenzie Jonathan Barrett | MED | Common Stock | D | 9.5900 | -862 | -8 | 10,008 | ||||
| 2026-03-27 | 2026-03-17 | 4 | MacKenzie Jonathan Barrett | MED | Common Stock | D | 10.0500 | -70 | -1 | 10,870 | ||||
| 2026-03-27 | 2026-03-13 | 4 | MacKenzie Jonathan Barrett | MED | Common Stock | D | 9.6200 | -198 | -2 | 10,940 | ||||
| 2025-03-27 | 2025-03-25 | 4 | MacKenzie Jonathan Barrett | MED | Common Stock | D | 7,671 | 11,138 | ||||||
| 2025-03-18 | 2025-03-17 | 4 | MacKenzie Jonathan Barrett | MED | Common Stock | D | 14.3500 | -99 | -1 | 3,467 | ||||
| 2025-03-18 | 2025-03-16 | 4 | MacKenzie Jonathan Barrett | MED | Common Stock | D | 13.9400 | -60 | -1 | 3,566 | ||||
| 2025-03-18 | 2025-03-13 | 4 | MacKenzie Jonathan Barrett | MED | Common Stock | D | 13.8700 | -280 | -4 | 3,626 | ||||
| 2024-09-17 | 2024-09-13 | 4 | MacKenzie Jonathan Barrett | MED | Common Stock | D | 18.9000 | -11 | -0 | 3,906 | ||||
| 2024-03-19 | 2024-03-15 | 4 | MacKenzie Jonathan Barrett | MED | Common Stock | D | 36.6100 | -83 | -3 | 3,917 | ||||
| 2024-03-19 | 2024-03-15 | 4 | MacKenzie Jonathan Barrett | MED | Common Stock | D | 36.6100 | -51 | -2 | 4,000 | ||||
| 2024-03-15 | 2024-03-13 | 4 | MacKenzie Jonathan Barrett | MED | Common Stock | D | 2,565 | 4,051 | ||||||
| 2023-09-15 | 2023-09-13 | 4 | MacKenzie Jonathan Barrett | MED | Common Stock | D | 81.0800 | -10 | -1 | 1,486 | ||||
| 2023-05-01 | 2023-03-17 | 4 | MacKenzie Jonathan Barrett | MED | Common Stock | D | 906 | 1,496 | ||||||
| 2023-05-01 | 2023-03-16 | 4 | MacKenzie Jonathan Barrett | MED | Common Stock | D | 104.4600 | -57 | -6 | 590 | ||||
| 2023-02-09 | 2022-09-13 | 4 | MacKenzie Jonathan Barrett | MED | Common Stock | D | 124.5600 | -10 | -1 | 647 | ||||
| 2022-03-21 | 2022-03-16 | 4 | MacKenzie Jonathan Barrett | MED | Common Stock | D | 548 | 657 | ||||||
| 2021-09-15 | 2021-09-13 | 4 | MacKenzie Jonathan Barrett | MED | Common Stock | D | 109 | 109 |
P
Acquisto sul mercato aperto o privato di un titolo non derivato o derivato
S
Vendita sul mercato aperto o privato di un titolo non derivato o derivato
A
Concessione, assegnazione o altra acquisizione di titoli dall'azienda (ad esempio un'opzione)
C
Conversione di un derivato
D
Vendita o trasferimento di titoli alla società
F
Pagamento del prezzo di esercizio o del debito fiscale con la quota di titoli ricevuta dalla società
G
Regalo di titoli da parte o a favore dell'insider
K
Equity swap e operazioni di copertura analoghe
M
Esercizio o conversione di un titolo derivato ricevuto dall'azienda (ad esempio un'opzione)
V
Una transazione dichiarata volontariamente sul modulo 4
J
Altro (accompagnato da una nota a piè di pagina che descriva l'operazione)
